| Abstrakt: |
Edge University researchers conducted a study on the interactions between propofol and long non-coding RNAs (lncRNAs) in MCF7 breast cancer cells. The research aimed to understand propofol's therapeutic potential in breast cancer treatment by analyzing its effects on cell viability, apoptosis, and lncRNA expressions. The study revealed that propofol regulates various lncRNAs in MCF7 cells and potentially targets chemotherapy resistance. This research sheds light on the complex interplay of lncRNAs and propofol's anti-cancer effects, offering new avenues for therapeutic exploration in breast cancer intervention. [Extracted from the article] |
